A detailed history of Aimz Investment Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Aimz Investment Advisors, LLC holds 16,064 shares of ABBV stock, worth $2.76 Million. This represents 1.1% of its overall portfolio holdings.

Number of Shares
16,064
Previous 16,360 1.81%
Holding current value
$2.76 Million
Previous $2.54 Million 15.38%
% of portfolio
1.1%
Previous 1.04%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$159.82 - $182.1 $47,306 - $53,901
-296 Reduced 1.81%
16,064 $2.93 Million
Q4 2023

Jan 26, 2024

SELL
$137.6 - $154.97 $42,243 - $47,575
-307 Reduced 1.84%
16,360 $2.54 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $12,824 - $14,846
-96 Reduced 0.57%
16,667 $2.48 Million
Q2 2023

Aug 08, 2023

BUY
$132.51 - $164.9 $397 - $494
3 Added 0.02%
16,763 $2.26 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $46,419 - $53,459
-321 Reduced 1.88%
16,760 $2.67 Million
Q4 2022

Feb 10, 2023

SELL
$138.31 - $165.87 $41,078 - $49,263
-297 Reduced 1.71%
17,081 $2.76 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $16,373 - $18,779
-122 Reduced 0.7%
17,378 $2.33 Million
Q2 2022

Aug 02, 2022

BUY
$137.62 - $174.96 $412 - $524
3 Added 0.02%
17,500 $2.68 Million
Q1 2022

May 06, 2022

SELL
$131.98 - $163.75 $105,188 - $130,508
-797 Reduced 4.36%
17,497 $2.84 Million
Q4 2021

Feb 09, 2022

BUY
$107.43 - $135.93 $54,144 - $68,508
504 Added 2.83%
18,294 $2.48 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $425 - $483
4 Added 0.02%
17,790 $1.92 Million
Q2 2021

Aug 05, 2021

BUY
$105.21 - $117.21 $315 - $351
3 Added 0.02%
17,786 $2 Million
Q1 2021

Apr 28, 2021

SELL
$102.3 - $112.62 $13,810 - $15,203
-135 Reduced 0.75%
17,783 $1.92 Million
Q4 2020

Feb 08, 2021

BUY
$80.49 - $108.67 $3,461 - $4,672
43 Added 0.24%
17,918 $1.92 Million
Q3 2020

Nov 13, 2020

BUY
$85.91 - $100.83 $343 - $403
4 Added 0.02%
17,875 $1.57 Million
Q2 2020

Aug 07, 2020

SELL
$73.37 - $98.18 $1,760 - $2,356
-24 Reduced 0.13%
17,871 $1.76 Million
Q1 2020

May 12, 2020

SELL
$64.5 - $97.79 $9,481 - $14,375
-147 Reduced 0.81%
17,895 $1.36 Million
Q4 2019

Feb 13, 2020

SELL
$72.13 - $90.25 $6,924 - $8,664
-96 Reduced 0.53%
18,042 $1.6 Million
Q3 2019

Nov 13, 2019

SELL
$62.98 - $75.72 $503 - $605
-8 Reduced 0.04%
18,138 $1.37 Million
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $262 - $335
4 Added 0.02%
18,146 $1.32 Million
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $308 - $363
4 Added 0.02%
18,142 $1.46 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $11,443 - $14,113
-147 Reduced 0.8%
18,138 $1.67 Million
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $8,713 - $9,686
-98 Reduced 0.53%
18,285 $1.73 Million
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $8,708 - $10,304
-97 Reduced 0.52%
18,383 $1.7 Million
Q1 2018

May 01, 2018

SELL
$92.01 - $123.21 $50,421 - $67,519
-548 Reduced 2.88%
18,480 $1.75 Million
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $17,822 - $19,543
-199 Reduced 1.04%
19,028 $1.84 Million
Q3 2017

Nov 01, 2017

BUY
$69.85 - $89.22 $209 - $267
3 Added 0.02%
19,227 $1.71 Million
Q2 2017

Aug 15, 2017

BUY
N/A
19,224
19,224 $1.39 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $303B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Aimz Investment Advisors, LLC Portfolio

Follow Aimz Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aimz Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aimz Investment Advisors, LLC with notifications on news.